SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-194946
Filing Date
2014-05-12
Accepted
2014-05-12 16:39:25
Documents
13
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d718415d10q.htm 10-Q 458052
2 EX-10.1 d718415dex101.htm EX-10.1 33985
3 EX-10.2 d718415dex102.htm EX-10.2 134003
4 EX-31.1 d718415dex311.htm EX-31.1 9111
5 EX-31.2 d718415dex312.htm EX-31.2 9090
6 EX-32.1 d718415dex321.htm EX-32.1 3984
7 EX-32.2 d718415dex322.htm EX-32.2 3995
  Complete submission text file 0001193125-14-194946.txt   2720786

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT cort-20140331.xml EX-101.INS 243859
9 XBRL TAXONOMY EXTENSION SCHEMA cort-20140331.xsd EX-101.SCH 24448
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cort-20140331_cal.xml EX-101.CAL 38380
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cort-20140331_def.xml EX-101.DEF 150849
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE cort-20140331_lab.xml EX-101.LAB 202847
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cort-20140331_pre.xml EX-101.PRE 177022
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50679 | Film No.: 14833872
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1